BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37820110)

  • 1. Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti.
    Alvarez OA; St Victor Dély N; Paul Hanna M; Saint Fleur R; Cetoute M; Metalonis S; Hustace T; Brown EC; Marcelin LH; Muscadin E; Eveillard R; Lerebours E
    Blood Adv; 2024 Jan; 8(1):14-22. PubMed ID: 37820110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned.
    Segbefia CI; Goka B; Welbeck J; Amegan-Aho K; Dwuma-Badu D; Rao S; Salifu N; Oppong SA; Odei E; Ohene-Frempong K; Odame I
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29068. PubMed ID: 33890391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests.
    Olaniyan HS; Briscoe C; Muhongo M; Pascoal R; Armando A; Santos B; McGann PT
    Blood Adv; 2023 Oct; 7(19):5860-5867. PubMed ID: 37399450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Quality of Care Indicators and Location of Sickle Cell Care Within Indiana.
    Meier ER; Janson IA; Hampton K; Bloom E; Duncan N; Roberson C; Rampersad A
    J Community Health; 2020 Feb; 45(1):81-87. PubMed ID: 31396825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis.
    Lang CW; Stark AP; Acharya K; Ross LF
    Am J Med Genet A; 2009 Nov; 149A(11):2424-9. PubMed ID: 19876910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
    Mano RM; Kuona P; Misihairabgwi JM
    BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health education to promote knowledge about sickle cell disease and newborn screening in pregnant women: a community-based pilot study using the healthy beginning initiative.
    Ezenwosu OU; Olawepo JO; Lacroix-Willliamson LJ; Itanyi IU; Ogidi A; Onyeka TC; Gully M; Gregory M; Breeze JL; Ibemere S; Idemili-Aronu N; Molnar BE; Ezeanolue EE
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):321. PubMed ID: 38671412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Newborn screening for sickle cell disease in France].
    Brousse V; Allaf B; Benkerrou M
    Med Sci (Paris); 2021 May; 37(5):482-490. PubMed ID: 34003094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns.
    Lobitz S; Klein J; Brose A; Blankenstein O; Frömmel C
    Ann Hematol; 2019 Jan; 98(1):47-53. PubMed ID: 30132072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of Newborn Screening for Sickle Cell Disease among Post-Partum Mothers in Abakaliki, South East Nigeria.
    Nnachi OC; Umeokonkwo AA; Okoye HC; Ekwe AN; Akpa CO; Okoye AE
    West Afr J Med; 2023 Mar; 40(3):298-304. PubMed ID: 37017939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B; Patin F; Elion J; Couque N
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
    Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.